By Counterforce Health Team in Fabrazyme (agalsidase beta) —

How to Get Fabrazyme (agalsidase beta) Covered by Humana in New York: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Fabrazyme Covered by Humana in New York

Fastest path to approval: Submit prior authorization with genetic/biochemical confirmation of Fabry disease, specialist prescriber letter, and documentation of medical necessity. Humana typically decides within 72 hours standard (24 hours expedited). If denied, you have 65 days to appeal internally, then access Medicare's external review process. Start today: Call Humana member services to confirm formulary status and PA requirements for your specific plan.

Table of Contents

  1. What Drives Fabrazyme Coverage Costs
  2. Investigating Your Humana Benefits
  3. Prior Authorization Requirements
  4. Cost Assistance and Copay Programs
  5. Appeals Process for Denials
  6. Specialty Pharmacy and Administration
  7. Annual Renewal and Budget Planning
  8. Scripts for Key Conversations
  9. FAQ

What Drives Fabrazyme Coverage Costs

Fabrazyme (agalsidase beta) is a specialty enzyme replacement therapy for Fabry disease that typically costs around $1,100 per 5-mg vial and $7,600 per 35-mg vial for cash-pay patients. Your out-of-pocket costs with Humana depend on several factors:

Formulary Tier Placement: Fabrazyme is likely placed on Tier 4 (Specialty) in most Humana Medicare Advantage plans, though specific tier placement varies by plan. Specialty tier medications typically have the highest cost-sharing, often 25-33% coinsurance rather than flat copays.

Prior Authorization Requirements: Most Humana plans require prior authorization for Fabrazyme, which can delay access but doesn't necessarily increase costs once approved. The PA process verifies medical necessity and appropriate prescriber credentials.

Medicare Part D Out-of-Pocket Cap: For 2025, Medicare Part D plans include a $2,000 annual out-of-pocket maximum cap. Once you reach this limit, your plan covers the full cost of covered medications for the remainder of the year.

Note: Humana Medicare Advantage plans have higher out-of-pocket limits: $9,350 for in-network services and $14,000 for combined coverage in 2025.

Investigating Your Humana Benefits

Before starting treatment, gather this essential information about your specific Humana plan:

Coverage Verification Checklist

  • Formulary status: Is Fabrazyme covered on your plan's drug list?
  • Tier placement: Which tier determines your cost-sharing?
  • Prior authorization: Required before first fill or annually?
  • Step therapy: Must you try alternatives like Galafold first?
  • Quantity limits: Any restrictions on dosing or frequency?
  • Site of care: Coverage for infusion centers vs. home administration?
  • Network requirements: Preferred specialty pharmacies or infusion centers?

Key Information to Record

When you call Humana member services, document:

  • Representative name and reference number
  • Specific plan name and formulary year
  • Exact PA requirements and forms needed
  • Timeline for decisions (standard vs. expedited)
  • Appeals process and deadlines
  • In-network specialty pharmacy options in New York

Contact Humana: Call the member services number on your ID card or visit MyHumana to search your specific plan's coverage.

Prior Authorization Requirements

Humana typically requires prior authorization for Fabrazyme with these standard criteria:

Medical Necessity Documentation

Your prescriber must submit:

  1. Confirmed Fabry disease diagnosis with genetic testing or biochemical confirmation (alpha-galactosidase A deficiency)
  2. Specialist prescriber (typically geneticist, nephrologist, or cardiologist experienced in Fabry disease)
  3. Clinical rationale explaining why Fabrazyme is medically necessary
  4. Dosing justification based on weight and clinical guidelines (standard: 1 mg/kg every 2 weeks)
  5. Treatment goals and monitoring plan

Common Denial Reasons and Solutions

Denial Reason How to Overturn
No genetic confirmation Submit genetic test results showing GLA gene mutation
Non-specialist prescriber Transfer prescription to qualified specialist or request consultation
Preference for oral therapy Document contraindications to Galafold or amenable variant status
Insufficient documentation Provide complete medical records and specialist letter

Timeline and Submission

  • Standard decisions: 72 hours from complete submission
  • Expedited decisions: 24 hours if health is at serious risk
  • Submission method: Fax to 877-486-2621 or through provider portal
Tip: Request expedited review if you're currently stable on Fabrazyme or if delays could worsen kidney, heart, or neurological symptoms.

Cost Assistance and Copay Programs

Sanofi Patient Support

Sanofi offers copay assistance and patient support programs for Fabrazyme, though specific eligibility requirements should be verified directly with Sanofi Patient Connection.

Important limitation: Medicare beneficiaries are generally not eligible for manufacturer copay assistance programs due to federal anti-kickback laws.

Alternative Financial Support

  • Bridge therapy: Sanofi provides temporary supply (30-60 days) while appeals are processed
  • Patient assistance programs: Income-based free drug programs for uninsured or underinsured patients
  • Foundation grants: Organizations like the National Fabry Disease Foundation may offer financial assistance

Medicare-Specific Benefits

  • Part D out-of-pocket cap: $2,000 maximum in 2025 for all covered medications
  • Low-income subsidies: Extra Help programs can reduce premiums and cost-sharing
  • State pharmaceutical assistance: New York EPIC program may provide additional support for eligible seniors

Appeals Process for Denials

If Humana denies coverage for Fabrazyme, you have multiple appeal levels available:

Internal Appeals (First Level)

Timeline: You have 65 calendar days from denial to request internal appeal

How to file:

  • Online through MyHumana portal
  • Phone: Customer service number on your ID card
  • Mail or fax: Address provided in denial letter
  • Required: Denial letter, supporting medical records, prescriber statement

Decision timeline:

  • Standard: 30 days for coverage decisions
  • Expedited: 72 hours if delay could seriously jeopardize health

Medicare External Review

Important: New York State's external appeal process does not apply to Medicare Advantage plans like Humana. Medicare beneficiaries must use Medicare's appeal system.

Medicare appeals process:

  • Independent Review Entity (IRE) review after internal appeal
  • Quality Improvement Organization (QIO) for expedited appeals
  • Administrative Law Judge hearing for higher-dollar disputes

Required Documentation for Appeals

Include these materials with your appeal:

  • Complete denial letter and claim information
  • Medical records supporting Fabry disease diagnosis
  • Specialist letter explaining medical necessity
  • Documentation of failed alternatives (if applicable)
  • Published treatment guidelines or studies supporting Fabrazyme use
From our advocates: "We've seen the strongest appeals include both the genetic testing that confirms Fabry disease and a detailed letter from the treating specialist explaining why enzyme replacement therapy is necessary for this specific patient's symptoms and organ involvement. The more specific the clinical justification, the better the outcome."

Specialty Pharmacy and Administration

Fabrazyme requires special handling and is typically distributed through specialty pharmacies rather than retail pharmacies.

Finding In-Network Providers

Contact Humana to identify:

  • Specialty pharmacies: In-network options for Fabrazyme distribution in New York
  • Infusion centers: Approved sites for IV administration
  • Home infusion: Whether your plan covers home administration services

Coordination Tips

  • Prior authorization: Ensure both the drug and administration site are pre-approved
  • Scheduling: Coordinate delivery and infusion appointments (every 2 weeks)
  • Monitoring: Arrange for required lab work and specialist follow-ups
  • Supply management: Plan for holiday schedules and travel

Counterforce Health helps patients navigate these complex specialty pharmacy requirements by coordinating with payers, providers, and pharmacies to ensure smooth access to treatments like Fabrazyme.

Annual Renewal and Budget Planning

Humana coverage can change annually, affecting your Fabrazyme access and costs:

What Can Change Each Year

  • Formulary placement: Tier level or coverage status
  • Prior authorization requirements: New criteria or documentation needs
  • Network changes: Preferred specialty pharmacies or infusion centers
  • Cost-sharing: Copay amounts or coinsurance percentages
  • Benefit design: Deductibles, out-of-pocket maximums

Renewal Timeline

  • October-November: Review Annual Notice of Change (ANOC)
  • December: Open enrollment period for plan changes
  • January: New benefit year begins; may need new PA
  • Throughout year: Monitor for mid-year formulary changes

Budget Planning

With the 2025 Medicare Part D out-of-pocket cap of $2,000, most patients will reach maximum cost-sharing early in the year with specialty medications like Fabrazyme. Plan for higher costs in early months, then $0 cost-sharing once the cap is reached.

Scripts for Key Conversations

Calling Humana Member Services

"Hi, I'm calling to verify coverage for Fabrazyme, spelled F-A-B-R-A-Z-Y-M-E, for Fabry disease. I need to know the formulary tier, whether prior authorization is required, and what documentation my doctor needs to submit. Can you also provide the fax number for PA submissions and expected timeline for decisions?"

Requesting Expedited Review

"My doctor is requesting expedited prior authorization for Fabrazyme because I have Fabry disease with [kidney/heart/neurological] involvement, and delays in treatment could seriously worsen my condition. What additional documentation do you need for the expedited review?"

Provider Office Coordination

"I'm working with my insurance to get Fabrazyme approved. Can you help me gather the genetic testing results, current lab values, and a letter explaining why this medication is medically necessary for my Fabry disease? I also need documentation of any previous treatments we've tried."

FAQ

How long does Humana prior authorization take for Fabrazyme in New York? Standard decisions are made within 72 hours; expedited decisions within 24 hours if your health could be seriously jeopardized by delays.

What if Fabrazyme is not on Humana's formulary? You can request a formulary exception with medical necessity documentation. The prescriber must submit a supporting statement explaining why Fabrazyme is medically necessary.

Can I appeal a Humana denial in New York State? Medicare beneficiaries cannot use New York's state external appeal process. You must follow Medicare's internal and external appeal procedures through Humana and Medicare's Independent Review Entity.

Does Humana require step therapy before approving Fabrazyme? This varies by plan. Some may require trying Galafold (migalastat) first if you have an amenable GLA variant. Check your specific plan's coverage criteria.

What happens if I move from another state to New York? Your Humana coverage terms remain the same, but you may need to establish care with new in-network specialists and infusion centers in New York.

How much will Fabrazyme cost with Humana in 2025? With the Medicare Part D out-of-pocket cap of $2,000, you'll pay no more than $2,000 annually for all covered medications, including Fabrazyme.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Coverage policies and requirements may vary by specific Humana plan and can change. Always verify current coverage details with Humana directly and consult your healthcare provider for medical decisions. For additional help with insurance appeals in New York, contact Community Health Advocates at 888-614-5400.

When navigating complex prior authorization and appeal processes, Counterforce Health provides specialized support to help patients, clinicians, and specialty pharmacies turn insurance denials into successful, evidence-backed appeals for treatments like Fabrazyme.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.